Peter Lundbäck

2.7k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

Peter Lundbäck is a scholar working on Clinical Biochemistry, Molecular Biology and Immunology. According to data from OpenAlex, Peter Lundbäck has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Biochemistry, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Peter Lundbäck's work include Advanced Glycation End Products research (15 papers), Immune Response and Inflammation (7 papers) and Inflammasome and immune disorders (4 papers). Peter Lundbäck is often cited by papers focused on Advanced Glycation End Products research (15 papers), Immune Response and Inflammation (7 papers) and Inflammasome and immune disorders (4 papers). Peter Lundbäck collaborates with scholars based in Sweden, United States and United Kingdom. Peter Lundbäck's co-authors include Jan Andersson, Helena Erlandsson-Harris, Kevin J. Tracey, Haichao Wang, Jianhua Li, Sangeeta S. Chavan, Ben Lü, Daniel J. Antoine, Huan Yang and Karin Palmblad and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Peter Lundbäck

21 papers receiving 1.6k citations

Hit Papers

Novel role of PKR in inflammasome activation and HMGB1 re... 2012 2026 2016 2021 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lundbäck Sweden 13 702 636 586 162 154 21 1.6k
Ari Rouhiainen Finland 17 598 0.9× 753 1.2× 1.1k 1.9× 243 1.5× 121 0.8× 22 1.8k
Antonella Antonelli Italy 10 561 0.8× 413 0.6× 855 1.5× 96 0.6× 147 1.0× 12 1.6k
Lizhi Cao China 9 633 0.9× 310 0.5× 447 0.8× 220 1.4× 99 0.6× 25 1.5k
Hanna Schierbeck Sweden 11 335 0.5× 508 0.8× 551 0.9× 62 0.4× 58 0.4× 16 1.2k
David Stern United States 6 1.0k 1.5× 531 0.8× 1.4k 2.3× 178 1.1× 612 4.0× 8 2.6k
Yacheng Pan China 7 403 0.6× 214 0.3× 1.1k 1.8× 74 0.5× 230 1.5× 10 1.5k
Gavin C. Higgins Australia 21 573 0.8× 165 0.3× 188 0.3× 239 1.5× 173 1.1× 31 1.4k
Jeremy S. Tilstra United States 14 710 1.0× 515 0.8× 94 0.2× 113 0.7× 378 2.5× 21 1.7k
Pin-Lan Li United States 19 1.4k 2.0× 402 0.6× 87 0.1× 314 1.9× 169 1.1× 26 2.0k
Carine Bossenmeyer‐Pourié France 21 594 0.8× 259 0.4× 103 0.2× 81 0.5× 177 1.1× 46 1.5k

Countries citing papers authored by Peter Lundbäck

Since Specialization
Citations

This map shows the geographic impact of Peter Lundbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lundbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lundbäck more than expected).

Fields of papers citing papers by Peter Lundbäck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lundbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lundbäck. The network helps show where Peter Lundbäck may publish in the future.

Co-authorship network of co-authors of Peter Lundbäck

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lundbäck. A scholar is included among the top collaborators of Peter Lundbäck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lundbäck. Peter Lundbäck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guterstam, Peter, et al.. (2024). Improved mRNA affinity chromatography binding capacity and throughput using an oligo-dT immobilized electrospun polymer nanofiber adsorbent. Journal of Chromatography A. 1717. 464670–464670. 16 indexed citations
2.
Sundnes, Olav, William Ottestad, Camilla Schjalm, et al.. (2021). Rapid systemic surge of IL-33 after severe human trauma: a prospective observational study. Molecular Medicine. 27(1). 29–29. 10 indexed citations
3.
Yang, Huan, Peter Lundbäck, Lars Ottosson, et al.. (2021). Redox modifications of cysteine residues regulate the cytokine activity of HMGB1. Molecular Medicine. 27(1). 58–58. 41 indexed citations
4.
Lundbäck, Peter, Kevin J. Tracey, Yong-Rui Zou, et al.. (2021). Novel role of PKR in inflammasome activation and HMGB1 release. UNC Libraries. 2 indexed citations
5.
Lundbäck, Peter, et al.. (2020). 3PO inhibits inflammatory NFκB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3. PLoS ONE. 15(3). e0229395–e0229395. 12 indexed citations
6.
Sowińska, Agnieszka, et al.. (2020). Cleavage of HMGB1 by Proteolytic Enzymes Associated with Inflammatory Conditions. Frontiers in Immunology. 11. 448262–448262. 12 indexed citations
7.
Agalave, Nilesh M., Alex Bersellini Farinotti, Peter Lundbäck, et al.. (2020). Sex- and cell-dependent contribution of peripheral high mobility group box 1 and TLR4 in arthritis-induced pain. Pain. 162(2). 459–470. 34 indexed citations
8.
Ottestad, William, et al.. (2019). HMGB1 concentration measurements in trauma patients: assessment of pre-analytical conditions and sample material. Molecular Medicine. 26(1). 5–5. 11 indexed citations
9.
Sowińska, Agnieszka, et al.. (2018). Ligation of free HMGB1 to TLR2 in the absence of ligand is negatively regulated by the C-terminal tail domain. Molecular Medicine. 24(1). 19–19. 27 indexed citations
10.
Aulin, Cecilia, Peter Lundbäck, Karin Palmblad, Lars Klareskog, & Helena Erlandsson Harris. (2016). An in vivo cross-linkable hyaluronan gel with inherent anti-inflammatory properties reduces OA cartilage destruction in female mice subjected to cruciate ligament transection. Osteoarthritis and Cartilage. 25(1). 157–165. 10 indexed citations
11.
Lundbäck, Peter, Agnieszka Sowińska, Lars Ottosson, et al.. (2016). A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug‐induced liver injury and postinjury inflammation in mice. Hepatology. 64(5). 1699–1710. 78 indexed citations
12.
Agalave, Nilesh M., Sally Abdelmoaty, Peter Lundbäck, et al.. (2015). Spinal disulfide HMGB1, but not all-thiol HMGB1, induces mechanical hypersensitivity in a TLR4-dependent manner. Scandinavian Journal of Pain. 8(1). 47–47. 1 indexed citations
13.
Lü, Ben, Daniel J. Antoine, Kevin Kwan, et al.. (2014). JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proceedings of the National Academy of Sciences. 111(8). 3068–3073. 298 indexed citations
14.
Agalave, Nilesh M., Max Larsson, Sally Abdelmoaty, et al.. (2014). Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain. 155(9). 1802–1813. 154 indexed citations
15.
Lundbäck, Peter, Pernilla Stridh, Lena Klevenvall, et al.. (2014). Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis. Antioxidants and Redox Signaling. 24(12). 605–619. 22 indexed citations
16.
Nyström, Sanna, Daniel J. Antoine, Peter Lundbäck, et al.. (2013). TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. The EMBO Journal. 32(1). 172–172. 4 indexed citations
17.
Nyström, Sanna, Daniel J. Antoine, Peter Lundbäck, et al.. (2012). TLR activation regulates damage‐associated molecular pattern isoforms released during pyroptosis. The EMBO Journal. 32(1). 86–99. 110 indexed citations
18.
Ottosson, Lars, Peter Lundbäck, Hulda S. Hreggvidsdottir, et al.. (2012). The pro-inflammatory effect of HMGB1, a mediator of inflammation in arthritis, is dependent on the redox status of the protein. Annals of the Rheumatic Diseases. 71. A81–A82. 1 indexed citations
19.
Lü, Ben, Takahisa Nakamura, Karen Inouye, et al.. (2012). Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 488(7413). 670–674. 632 indexed citations breakdown →
20.
Schierbeck, Hanna, Peter Lundbäck, Karin Palmblad, et al.. (2011). Monoclonal Anti-HMGB1 (High Mobility Group Box Chromosomal Protein 1) Antibody Protection in Two Experimental Arthritis Models. Molecular Medicine. 17(9-10). 1039–1044. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026